MedTrace Logo

Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism

NCT04088292 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2024-11-15

No results posted yet for this study

Summary

Open label clinical randomized trial comparing three strategies for managing acute intermediate-high risk pulmonary embolism

Conditions

Interventions

DRUG

Alteplase 20 Mg Powder for Solution for Injection Vial

Low dose alteplase delivered IV or bu Ultrasound Assisted Thrombolysis device

DEVICE

Ultrasound assisted Thrombolysis

Ultrasound assisted thrombolysis (USAT)

Sponsors & Collaborators

  • Herlev and Gentofte Hospital

    collaborator OTHER

  • University Hospital Bispebjerg and Frederiksberg

    collaborator OTHER

  • Hillerod Hospital, Denmark

    collaborator OTHER

  • Copenhagen University Hospital, Hvidovre

    collaborator OTHER

  • Rigshospitalet, Denmark

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-06
Primary Completion
2024-06-05
Completion
2024-11-30
FDA Drug
Yes
FDA Device
Yes

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04088292 on ClinicalTrials.gov